| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| IART - Integra LifeSciences Holdings | HOLD | 0 @ USD 11.81 | USD 0 | The current share valuation price of IART based on adjusted close was USD 11.81. The average price that IART shares were previous bought at was USD 18.083. The current market price is -34.7% lower than average price they were purchased at. The value of the holding in IART has fallen by USD 34,701 compared to the previous valuation of Integra LifeSciences Holdings |
| TMCI - Treace Medical Concepts Inc | SELL | -168 @ USD 6.35001 | USD -1,067 | The ETF sold 168 shares of TMCI on 2025-10-30. The shares were previously bought for an average price of USD 7.63756. The Treace Medical Concepts Inc shares were sold for -16.9% lower than average price of previous purchases. This resulted in an overall loss of USD 216 The average price that the ETF previously sold TMCI share for is USD 7.38575 which is higher than the selling price of USD 6.35001 on 2025-10-30. |
| SRDX - SurModics Inc | SELL | -54 @ USD 27.1702 | USD -1,467 | The ETF sold 54 shares of SRDX on 2025-10-30. The shares were previously bought for an average price of USD 30.7598. The SurModics Inc shares were sold for -11.7% lower than average price of previous purchases. This resulted in an overall loss of USD 194 The average price that the ETF previously sold SRDX share for is USD 33.1914 which is higher than the selling price of USD 27.1702 on 2025-10-30. |
| VREX - Varex Imaging Corp | SELL | -150 @ USD 11.8501 | USD -1,778 | The ETF sold 150 shares of VREX on 2025-10-30. The shares were previously bought for an average price of USD 11.3404. The Varex Imaging Corp shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of USD 76 The average price that the ETF previously sold VREX share for is USD 11.9437 which is higher than the selling price of USD 11.8501 on 2025-10-30. |
| SIBN - Si-Bone Inc | SELL | -135 @ USD 15.15 | USD -2,045 | The ETF sold 135 shares of SIBN on 2025-10-30. The shares were previously bought for an average price of USD 15.3586. The Si-Bone Inc shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 28 The average price that the ETF previously sold SIBN share for is USD 16.1325 which is higher than the selling price of USD 15.15 on 2025-10-30. |
| OFIX - Orthofix Medical Inc | SELL | -135 @ USD 15.4699 | USD -2,088 | The ETF sold 135 shares of OFIX on 2025-10-30. The shares were previously bought for an average price of USD 15.4195. The Orthofix Medical Inc shares were sold for 0.3% higher than average price of previous purchases. This sale made a profit of USD 7 The average price that the ETF previously sold OFIX share for is USD 15.1019 so the ETF has sold 135 shares on 2025-10-30 at a higher price than the previous selling average. |
| AXGN - Axogen Inc | SELL | -150 @ USD 22.68 | USD -3,402 | The ETF sold 150 shares of AXGN on 2025-10-30. The shares were previously bought for an average price of USD 16.1183. The Axogen Inc shares were sold for 40.7% higher than average price of previous purchases. This sale made a profit of USD 984 The average price that the ETF previously sold AXGN share for is USD 13.1744 so the ETF has sold 150 shares on 2025-10-30 at a higher price than the previous selling average. |
| TNDM - Tandem Diabetes Care Inc | SELL | -243 @ USD 14.59 | USD -3,545 | The ETF sold 243 shares of TNDM on 2025-10-30. The shares were previously bought for an average price of USD 21.1382. The Tandem Diabetes Care Inc shares were sold for -31.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,591 The average price that the ETF previously sold TNDM share for is USD 25.1942 which is higher than the selling price of USD 14.59 on 2025-10-30. |
| NVCR - Novocure Ltd | SELL | -348 @ USD 12.82 | USD -4,461 | The ETF sold 348 shares of NVCR on 2025-10-30. The shares were previously bought for an average price of USD 17.9917. The Novocure Ltd shares were sold for -28.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,800 The average price that the ETF previously sold NVCR share for is USD 20.823 which is higher than the selling price of USD 12.82 on 2025-10-30. |
| CNMD - CONMED Corporation | SELL | -105 @ USD 44.4901 | USD -4,671 | The ETF sold 105 shares of CNMD on 2025-10-30. The shares were previously bought for an average price of USD 56.9758. The CONMED Corporation shares were sold for -21.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,311 The average price that the ETF previously sold CNMD share for is USD 64.6229 which is higher than the selling price of USD 44.4901 on 2025-10-30. |
| OMCL - Omnicell Inc | SELL | -159 @ USD 33.58 | USD -5,339 | The ETF sold 159 shares of OMCL on 2025-10-30. The shares were previously bought for an average price of USD 34.6329. The Omnicell Inc shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of USD 167 The average price that the ETF previously sold OMCL share for is USD 37.7365 which is higher than the selling price of USD 33.58 on 2025-10-30. |
| ATRC - AtriCure Inc | SELL | -168 @ USD 34.09 | USD -5,727 | The ETF sold 168 shares of ATRC on 2025-10-30. The shares were previously bought for an average price of USD 35.5195. The AtriCure Inc shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 240 The average price that the ETF previously sold ATRC share for is USD 34.7299 which is higher than the selling price of USD 34.09 on 2025-10-30. |
| ENOV - Enovis Corp | SELL | -195 @ USD 30.69 | USD -5,985 | The ETF sold 195 shares of ENOV on 2025-10-30. The shares were previously bought for an average price of USD 36.5852. The Enovis Corp shares were sold for -16.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,150 The average price that the ETF previously sold ENOV share for is USD 39.6713 which is higher than the selling price of USD 30.69 on 2025-10-30. |
| LMAT - LeMaitre Vascular Inc | SELL | -69 @ USD 88.5501 | USD -6,110 | The ETF sold 69 shares of LMAT on 2025-10-30. The shares were previously bought for an average price of USD 88.5943. The LeMaitre Vascular Inc shares were sold for 0.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3 The average price that the ETF previously sold LMAT share for is USD 92.5134 which is higher than the selling price of USD 88.5501 on 2025-10-30. |
| QDEL - Quidel Corporation | SELL | -231 @ USD 26.81 | USD -6,193 | The ETF sold 231 shares of QDEL on 2025-10-30. The shares were previously bought for an average price of USD 34.4553. The Quidel Corporation shares were sold for -22.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,766 The average price that the ETF previously sold QDEL share for is USD 35.5331 which is higher than the selling price of USD 26.81 on 2025-10-30. |
| ATEC - Alphatec Holdings Inc | SELL | -384 @ USD 16.33 | USD -6,271 | The ETF sold 384 shares of ATEC on 2025-10-30. The shares were previously bought for an average price of USD 13.0979. The Alphatec Holdings Inc shares were sold for 24.7% higher than average price of previous purchases. This sale made a profit of USD 1,241 The average price that the ETF previously sold ATEC share for is USD 11.2544 so the ETF has sold 384 shares on 2025-10-30 at a higher price than the previous selling average. |
| AORT - Artivion Inc | SELL | -138 @ USD 45.6499 | USD -6,300 | The ETF sold 138 shares of AORT on 2025-10-30. The shares were previously bought for an average price of USD 34.4703. The Artivion Inc shares were sold for 32.4% higher than average price of previous purchases. This sale made a profit of USD 1,543 The average price that the ETF previously sold AORT share for is USD 28.9064 so the ETF has sold 138 shares on 2025-10-30 at a higher price than the previous selling average. |
| PRCT - Procept Biorobotics Corp | SELL | -186 @ USD 34.38 | USD -6,395 | The ETF sold 186 shares of PRCT on 2025-10-30. The shares were previously bought for an average price of USD 59.9589. The Procept Biorobotics Corp shares were sold for -42.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,758 The average price that the ETF previously sold PRCT share for is USD 73.5139 which is higher than the selling price of USD 34.38 on 2025-10-30. |
| INSP - Inspirit Energy Holdings Plc | SELL | -90 @ USD 73.07 | USD -6,576 | The ETF sold 90 shares of INSP on 2025-10-30. The shares were previously bought for an average price of USD 136.677. The Inspirit Energy Holdings Plc shares were sold for -46.5% lower than average price of previous purchases. This resulted in an overall loss of USD 5,725 The average price that the ETF previously sold INSP share for is USD 153.216 which is higher than the selling price of USD 73.07 on 2025-10-30. |
| ITGR - Integer Holdings Corp | SELL | -114 @ USD 63.3199 | USD -7,218 | The ETF sold 114 shares of ITGR on 2025-10-30. The shares were previously bought for an average price of USD 119.063. The Integer Holdings Corp shares were sold for -46.8% lower than average price of previous purchases. This resulted in an overall loss of USD 6,355 The average price that the ETF previously sold ITGR share for is USD 128.161 which is higher than the selling price of USD 63.3199 on 2025-10-30. |
| LIVN - LivaNova PLC | SELL | -177 @ USD 52.79 | USD -9,344 | The ETF sold 177 shares of LIVN on 2025-10-30. The shares were previously bought for an average price of USD 46.565. The LivaNova PLC shares were sold for 13.4% higher than average price of previous purchases. This sale made a profit of USD 1,102 The average price that the ETF previously sold LIVN share for is USD 47.7774 so the ETF has sold 177 shares on 2025-10-30 at a higher price than the previous selling average. |
| NVST - Envista Holdings Corp | SELL | -558 @ USD 20.14 | USD -11,238 | The ETF sold 558 shares of NVST on 2025-10-30. The shares were previously bought for an average price of USD 19.1014. The Envista Holdings Corp shares were sold for 5.4% higher than average price of previous purchases. This sale made a profit of USD 580 The average price that the ETF previously sold NVST share for is USD 19.9735 so the ETF has sold 558 shares on 2025-10-30 at a higher price than the previous selling average. |
| TMDX - TransMedics Group Inc | SELL | -111 @ USD 135.79 | USD -15,073 | The ETF sold 111 shares of TMDX on 2025-10-30. The shares were previously bought for an average price of USD 92.4191. The TransMedics Group Inc shares were sold for 46.9% higher than average price of previous purchases. This sale made a profit of USD 4,814 The average price that the ETF previously sold TMDX share for is USD 107.087 so the ETF has sold 111 shares on 2025-10-30 at a higher price than the previous selling average. |
| GKOS - Glaukos Corp | SELL | -186 @ USD 87.8 | USD -16,331 | The ETF sold 186 shares of GKOS on 2025-10-30. The shares were previously bought for an average price of USD 107.535. The Glaukos Corp shares were sold for -18.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,671 The average price that the ETF previously sold GKOS share for is USD 114.88 which is higher than the selling price of USD 87.8 on 2025-10-30. |
| TFX - Teleflex Incorporated | SELL | -144 @ USD 124.84 | USD -17,977 | The ETF sold 144 shares of TFX on 2025-10-30. The shares were previously bought for an average price of USD 142.8. The Teleflex Incorporated shares were sold for -12.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,586 The average price that the ETF previously sold TFX share for is USD 154.032 which is higher than the selling price of USD 124.84 on 2025-10-30. |
| IRTC - iRhythm Technologies Inc | SELL | -105 @ USD 184.12 | USD -19,333 | The ETF sold 105 shares of IRTC on 2025-10-30. The shares were previously bought for an average price of USD 128.015. The iRhythm Technologies Inc shares were sold for 43.8% higher than average price of previous purchases. This sale made a profit of USD 5,891 The average price that the ETF previously sold IRTC share for is USD 118.986 so the ETF has sold 105 shares on 2025-10-30 at a higher price than the previous selling average. |
| MASI - Masimo Corporation | SELL | -150 @ USD 141.54 | USD -21,231 | The ETF sold 150 shares of MASI on 2025-10-30. The shares were previously bought for an average price of USD 155.136. The Masimo Corporation shares were sold for -8.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,039 The average price that the ETF previously sold MASI share for is USD 169.26 which is higher than the selling price of USD 141.54 on 2025-10-30. |
| GMED - Globus Medical | SELL | -369 @ USD 60.72 | USD -22,406 | The ETF sold 369 shares of GMED on 2025-10-30. The shares were previously bought for an average price of USD 70.543. The Globus Medical shares were sold for -13.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,625 The average price that the ETF previously sold GMED share for is USD 72.0602 which is higher than the selling price of USD 60.72 on 2025-10-30. |
| PEN - Pennant International Group plc | SELL | -126 @ USD 231.54 | USD -29,174 | The ETF sold 126 shares of PEN on 2025-10-30. The shares were previously bought for an average price of USD 259.747. The Pennant International Group plc shares were sold for -10.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,554 The average price that the ETF previously sold PEN share for is USD 256.003 which is higher than the selling price of USD 231.54 on 2025-10-30. |
| PEN - PBF Energy Inc | SELL | -126 @ USD 231.54 | USD -29,174 | The ETF sold 126 shares of PEN on 2025-10-30. The shares were previously bought for an average price of USD 259.747. The PBF Energy Inc shares were sold for -10.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,554 The average price that the ETF previously sold PEN share for is USD 256.003 which is higher than the selling price of USD 231.54 on 2025-10-30. |
| BAX - Baxter International Inc | SELL | -1,671 @ USD 19.16 | USD -32,016 | The ETF sold 1671 shares of BAX on 2025-10-30. The shares were previously bought for an average price of USD 27.7276. The Baxter International Inc shares were sold for -30.9% lower than average price of previous purchases. This resulted in an overall loss of USD 14,316 The average price that the ETF previously sold BAX share for is USD 31.8117 which is higher than the selling price of USD 19.16 on 2025-10-30. |
| HOLX - Hologic Inc | SELL | -723 @ USD 73.93 | USD -53,451 | The ETF sold 723 shares of HOLX on 2025-10-30. The shares were previously bought for an average price of USD 66.8075. The Hologic Inc shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 5,150 The average price that the ETF previously sold HOLX share for is USD 69.1826 so the ETF has sold 723 shares on 2025-10-30 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -642 @ USD 99.56 | USD -63,918 | The ETF sold 642 shares of ZBH on 2025-10-30. The shares were previously bought for an average price of USD 102.401. The Zimmer Biomet Holdings Inc shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,824 The average price that the ETF previously sold ZBH share for is USD 103.107 which is higher than the selling price of USD 99.56 on 2025-10-30. |
| PODD - Insulet Corporation | SELL | -228 @ USD 311.95 | USD -71,125 | The ETF sold 228 shares of PODD on 2025-10-30. The shares were previously bought for an average price of USD 292.47. The Insulet Corporation shares were sold for 6.7% higher than average price of previous purchases. This sale made a profit of USD 4,441 The average price that the ETF previously sold PODD share for is USD 286.376 so the ETF has sold 228 shares on 2025-10-30 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -318 @ USD 236.19 | USD -75,108 | The ETF sold 318 shares of STE on 2025-10-30. The shares were previously bought for an average price of USD 229.396. The STERIS plc shares were sold for 3.0% higher than average price of previous purchases. This sale made a profit of USD 2,160 The average price that the ETF previously sold STE share for is USD 229.977 so the ETF has sold 318 shares on 2025-10-30 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -1,272 @ USD 68.2 | USD -86,750 | The ETF sold 1272 shares of DXCM on 2025-10-30. The shares were previously bought for an average price of USD 75.551. The DexCom Inc shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 9,350 The average price that the ETF previously sold DXCM share for is USD 80.6503 which is higher than the selling price of USD 68.2 on 2025-10-30. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -1,479 @ USD 75 | USD -110,925 | The ETF sold 1479 shares of GEHC on 2025-10-30. The shares were previously bought for an average price of USD 74.952. The GE HealthCare Technologies Inc. shares were sold for 0.1% higher than average price of previous purchases. This sale made a profit of USD 71 The average price that the ETF previously sold GEHC share for is USD 77.1228 which is higher than the selling price of USD 75 on 2025-10-30. |
| RMD - ResMed Inc | SELL | -474 @ USD 252.26 | USD -119,571 | The ETF sold 474 shares of RMD on 2025-10-30. The shares were previously bought for an average price of USD 244.817. The ResMed Inc shares were sold for 3.0% higher than average price of previous purchases. This sale made a profit of USD 3,528 The average price that the ETF previously sold RMD share for is USD 247.598 so the ETF has sold 474 shares on 2025-10-30 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -1,902 @ USD 83.48 | USD -158,779 | The ETF sold 1902 shares of EW on 2025-10-30. The shares were previously bought for an average price of USD 72.9427. The Edwards Lifesciences Corp shares were sold for 14.4% higher than average price of previous purchases. This sale made a profit of USD 20,042 The average price that the ETF previously sold EW share for is USD 73.7101 so the ETF has sold 1902 shares on 2025-10-30 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -258 @ USD 628.54 | USD -162,163 | The ETF sold 258 shares of IDXX on 2025-10-30. The shares were previously bought for an average price of USD 502.42. The IDEXX Laboratories Inc shares were sold for 25.1% higher than average price of previous purchases. This sale made a profit of USD 32,539 The average price that the ETF previously sold IDXX share for is USD 476.317 so the ETF has sold 258 shares on 2025-10-30 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -927 @ USD 179.38 | USD -166,285 | The ETF sold 927 shares of BDX on 2025-10-30. The shares were previously bought for an average price of USD 202.613. The Becton Dickinson and Company shares were sold for -11.5% lower than average price of previous purchases. This resulted in an overall loss of USD 21,537 The average price that the ETF previously sold BDX share for is USD 199.776 which is higher than the selling price of USD 179.38 on 2025-10-30. |
| MDT - Medtronic PLC | SELL | -4,146 @ USD 90.97 | USD -377,162 | The ETF sold 4146 shares of MDT on 2025-10-30. The shares were previously bought for an average price of USD 89.3942. The Medtronic PLC shares were sold for 1.8% higher than average price of previous purchases. This sale made a profit of USD 6,533 The average price that the ETF previously sold MDT share for is USD 87.1646 so the ETF has sold 4146 shares on 2025-10-30 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -1,113 @ USD 368.98 | USD -410,675 | The ETF sold 1113 shares of SYK on 2025-10-30. The shares were previously bought for an average price of USD 375.231. The Stryker Corporation shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 6,957 The average price that the ETF previously sold SYK share for is USD 384.52 which is higher than the selling price of USD 368.98 on 2025-10-30. |
| BSX - Boston Scientific Corporation | SELL | -4,794 @ USD 100.57 | USD -482,133 | The ETF sold 4794 shares of BSX on 2025-10-30. The shares were previously bought for an average price of USD 98.172. The Boston Scientific Corporation shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 11,496 The average price that the ETF previously sold BSX share for is USD 96.9114 so the ETF has sold 4794 shares on 2025-10-30 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -4,794 @ USD 100.57 | USD -482,133 | The ETF sold 4794 shares of BSX on 2025-10-30. The shares were previously bought for an average price of USD 98.172. The MULSTRXSSXIMETFP shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 11,496 The average price that the ETF previously sold BSX share for is USD 96.9114 so the ETF has sold 4794 shares on 2025-10-30 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -1,158 @ USD 530.02 | USD -613,763 | The ETF sold 1158 shares of ISRG on 2025-10-30. The shares were previously bought for an average price of USD 508.988. The Intuitive Surgical Inc shares were sold for 4.1% higher than average price of previous purchases. This sale made a profit of USD 24,355 The average price that the ETF previously sold ISRG share for is USD 529.874 so the ETF has sold 1158 shares on 2025-10-30 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -5,628 @ USD 124.67 | USD -701,643 | The ETF sold 5628 shares of ABT on 2025-10-30. The shares were previously bought for an average price of USD 128.715. The Abbott Laboratories shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 22,765 The average price that the ETF previously sold ABT share for is USD 127.127 which is higher than the selling price of USD 124.67 on 2025-10-30. |